NCT00911248 2019-04-12PTC299 for Treatment of Neurofibromatosis Type 2PTC TherapeuticsPhase 2 Terminated11 enrolled
NCT01158300 2015-05-04PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsPediatric Brain Tumor ConsortiumPhase 1 Completed28 enrolled